Every company has a story. Learn the playbooks that built the world’s greatest companies — and how you can apply them as a founder, operator, or investor.
…
continue reading
The CEO of the largest single investor in the world, Norges Bank Investment Management, interviews leaders of some of the largest companies in the world. You will get to know the leader, their strategy, leadership principles, and much more. Hosted on Acast. See acast.com/privacy for more information.
…
continue reading
Ask the Expert’s: It’s Personal features real questions from people with diabetes and answers from diabetes experts. Please join us for this Q&A series to hear practical tips on topics such as nutrition, medication management, and physical activity. This podcast series is brought to you through our Know Diabetes by Heart and Focus on Diabetes initiatives. If you have type 2 diabetes, your risk of developing cardiovascular disease is doubled. The American Diabetes Association, in collaboratio ...
…
continue reading
ACQ2 is Ben and David's conversations with expert founders and investors. Acquired the stories of great companies — and ACQ2 dives deeper into the lessons we can learn from them, often with the protagonists themselves.
…
continue reading
Episode 1: Hear Davida Kruger, NP and Julio Rosenstock, MD discuss important head-to-head data between a GLP-1 RA and DPP-4 inhibitor as an important consideration when making clinical decisions for patients with T2D. Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two oral antidiabetic therapies. Episode 3: Hear this clinical panel share a quick overview of the patient support resources availabl ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Know Diabetes by Heart™ Professional Education Podcast Series
American Heart Association and American Diabetes Association
The American Heart Association and the American Diabetes Association are excited to announce a new podcast series for healthcare professionals. Know Diabetes by Heart™ Professional Education Podcast Series focuses on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D). The series will consist of relevant cutting-edge topics such as up-to-date standards of care, guidelines and their implications for T2D and CVD, and approaches to shared decision making—among others. The Am ...
…
continue reading
The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing’s print and online coverage, which follows the industry’s biggest issues surrounding scale-up, technology innovations, regulations and more
…
continue reading
Replenish your inner leader with our executive elixir of wisdom, humor, and the power of human connection. CEO and vocal leadership expert Tina Dietz and her guests guide you through the dark forest of professional development to ignite your managerial magic with discussions on the most important topics we're facing in the workplace today. Visit http://DrinkFromTheWellPodcast.com for show notes, transcripts, and insights. About Your Host: Tina Dietz is the CEO of Twin Flames Studios—a full-s ...
…
continue reading
An inspiring and informational podcast for women ready to level up in all areas of their lives- whether it's with health, money, mindset, career, relationships, lifestyle and more. Ana offers insight, resources and practical tools that positively impact personal and business finances, home life, career, health and wellness for Women Warriors of every kind! Go on a very real-talk journey with Ana as she interviews coaches and subject matter experts on this variety of topics and join a communi ...
…
continue reading
I'm passionate about helping pharma field teams feel confident using technology to engage with healthcare professionals. I want them to feel good about themselves and achieve amazing results. To explore this topic, I've been interviewing inspiring pharma leaders to learn from them for this Digital Transformation Series. - Mehrnaz Campbell, Founder and CEO of Cheemia & Cheemia ReSET Author of The Omni Advantage
…
continue reading
The world of finance has a huge impact on all of us. This show aims to explore and unravel some of the mysteries surrounding the investing business, via interviews with masters of the real life money maze. Expect tips for mastering capital allocation, making better business decisions, strategies for taking your career to the next level, and revelatory profiles of leading industry figures. Whether you're a current or aspiring investment professional, a regular investor, or a student exploring ...
…
continue reading
Join Ankita a.k.a the HR Bandit for a fun-filled conversation on what’s happening around the world and its impact on how we work. News, events, research, crazy ideas, and work experiments – this podcast covers it all. So, grab a cup (glass) of coffee (wine), sit back, and enjoy the banter. The podcast is a part of the new workplace initiative and sponsored by the kind folks over at NHRDN Hyderabad. All views, expressed are that of the speakers and are not the positions, strategies, or opinio ...
…
continue reading
Welcome to the All Fired Up podcast, with your host Louise Adams! Louise is by nature a mild mannered clinical psychologist, but her alter ego – a FIERCE and fearless anti-diet crusader – is taking over! Louise specialises in helping people recover from disordered eating, and she’s COMPLETELY OVER trying to help people when the culture we live in is utterly sick, toxic, and screwed up when it comes to food, exercise, health, and body size. Louise cannot for a second longer take the rampant i ...
…
continue reading
OFF BIKE - A Podcast About Where Cycling Takes Us What happens when you get off the bike? Join the ex pro rider David Millar and the business anthropologist Mikkel B. Rasmussen while they explore what biking does for us beyond the ride. The question might sound banal, but it is actually not so easy to answer. David and Mikkel outline their ambitious plans for this brand new series of podcasts where they will interview a wide cross-section of people to investigate their journeys through life ...
…
continue reading
As President of the International Institute for Management Development - better known as IMD - Jean-François Manzoni has a direct line to some of the world’s most interesting and successful business leaders. In this new podcast, he shares that opportunity with you.In each episode, we’ll hear from a different CEO about the path that brought them to the C-suite, the insights they’ve gained at the top -- and the advice they’d like to pass on to the next generation.New episodes every other Thursday.
…
continue reading
An in-depth look at how ultra-endurance events place extreme and unique physiological demands on athletes. This podcast will feature athletes, and their support teams, talking about how they prepare and compete at the world's toughest events. Expect discussion around long-term preparation, nutrition, coping with environmental stressors and building psychologic toughness! Host: Nick Longworth has been hosting international sports technology and life science conferences for the last decade, an ...
…
continue reading
Welcome to Pharma Launch Secrets, a podcast by Evermed. We host honest, direct, actionable conversations with world-leading pharma launch experts that will help you stay up to date with trends and strategies to help you launch your product successfully.
…
continue reading
The adoption and usage of technology are going through a radical transformation. Just a decade ago investment in the right technology was often enough to gain that crucial competitive edge. But the increasingly tough competition, the accelerating technological development, and the mounting complexity now demand new ways of choosing, adopting, and handling technology in the enterprise. The possibilities - and the challenges - are the main theme of The Digital Edge, a podcast created by Comput ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Amneal's Parkinson's pill approved, Novo Nordisk withdraws Wegovy approval expansion bid, FDA delays BeiGene Tevimbra decision [The good, the bad, the ugly]
2:59
2:59
Play later
Play later
Lists
Like
Liked
2:59
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Amneal gets FDA nod for Parkinson’s pill The bad — Novo Nordisk withdraws bid for Wegovy label expansion in heart failure The ugly — FDA delays decision on BeiGene Tevimbra as a first-line therapy…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Risky Business: How Novo Nordisk's Marketing Machine Turned Weight Loss Drugs Into Cardiovascular Life Savers
1:05:03
1:05:03
Play later
Play later
Lists
Like
Liked
1:05:03
Hosted on Acast. See acast.com/privacy for more information.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk
38:48
38:48
Play later
Play later
Lists
Like
Liked
38:48
Rerun: “I'm very concerned that European citizens will have lack of access or much lower access to some of the new medicines” says CEO of Novo Nordisk. He also share some interesting perspectives about the importance of purpose and their new weight loss drug. The production team on this episode were PLAN-B’s Niklas Figenschau Johansen and Nikolai O…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ask the Experts: How to Recognize and Treat Disease Burnout
1:02:14
1:02:14
Play later
Play later
Lists
Like
Liked
1:02:14
Audience called in and asked questions of our experts about how to ease their mental load while managing a condition like diabetes. Listen to our Ask the Experts event to learn how to reduce your risk of heart disease, stroke, and kidney disease when living with type 2 diabetes. Find more helpful resources on the Know Diabetes by Heart website: kno…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pregúntale a los Expertos: Cómo Reconocer y Tratar el Agotamiento por la Enfermedad
1:02:23
1:02:23
Play later
Play later
Lists
Like
Liked
1:02:23
La audiencia llamó e hizo preguntas a nuestros expertos sobre cómo aliviar su carga mental mientras manejan una condición como la diabetes. Escucha nuestro evento Pregúntale a los Expertos para aprender a reducir tu riesgo de enfermedad cardíaca, derrame cerebral y enfermedad renal cuando vives con diabetes tipo 2. Encuentra más recursos útiles en …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Jane Sun: Travel, crisis management and female leadership
40:01
40:01
Play later
Play later
Lists
Like
Liked
40:01
When you are a travel company, how do you deal with a global pandemic? Trip.com CEO Jane Sun joins Nicolai Tangen in Oslo and share their most memorable trips and experiences. They also talk about corporate culture, AI in customer service, the travel industry and career building. Sun shares her view on female leadership, and gender equality in the …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Beyond Weight Loss? Time for a Change! Let's Reimagine My Channel with Fresh Ideas!
13:27
13:27
Play later
Play later
Lists
Like
Liked
13:27
Let's reimagine this channel together! I've loved sharing my experiences with Ozempic, but I'm curious: What kind of wellness content would YOU like to see on this channel that you would also find most valuable?😌🧘♀️ I'm feeling the need for a change and I want to hear YOUR voice! Let's brainstorm some fresh ideas together!😉 Support the Show.…
…
continue reading
Summer greetings from Acquired! Two items for this “mini-episode”: Tickets are now available for our live show at Chase Center in San Francisco, with special guests including Mark Zuckerberg (!). The show is Tuesday, September 10th, with doors opening at 5 PM for an hour of mingling with other listeners before the show starts at 6 PM. Huge thank yo…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
150: War or Peace? Why the World May Be More Dangerous than the 1930s - With General Sir Patrick Sanders, Former UK Chief of the General Staff
52:24
52:24
Play later
Play later
Lists
Like
Liked
52:24
In this episode we have the huge pleasure and privilege to talk to General Sir Patrick Sanders, who until June of this year served as Chief of the General Staff. As the professional head of the British Army he had responsibility for over 100,000 troops (including reserves), steering this key component of the UK’s defence apparatus through an increa…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Magnus Carlsen: Chess, Investing and Strategic thinking
1:01:04
1:01:04
Play later
Play later
Lists
Like
Liked
1:01:04
How can strategic thinking in chess be applied to investing? In this episode Magnus Carlsen and Nicolai Tangen discuss the comparison between business investing and chess. They also talk about risk, how to recover after losses, AI in chess, strategizing against different opponents and how to always explore and stay curious. Magnus also reflects on …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
FDA approves Adaptimmune therapy, halts vTv diabetes program; Sanofi sues Sarepta over Duchenne patents [The good, the bad, the ugly]
3:58
3:58
Play later
Play later
Lists
Like
Liked
3:58
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves Adaptimmune engineered cell therapy The bad — FDA puts clinical hold on vTv Therapeutics diabetes program The ugly — Sanofi sues Sarepta over manufacturing patents for Duchenne gene ther…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Weight Loss Drugs & Diet: What Kelly Clarkson DIDN'T Tell US! (The TODAY Show Reaction Video)
8:42
8:42
Play later
Play later
Lists
Like
Liked
8:42
Is Kelly Clarkson's weight loss journey sparking controversy? We dive into the headlines and explore concerns surrounding weight loss medication. This video reacts to The TODAY Show's discussion on Kelly & Whoopi's use of meds, and explores the importance of a balanced approach to weight loss! Support the Show.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
149: The $5 Trillion High Yield Debt Markets: Trouble Ahead or Compelling Returns? - With Victor Khosla, Founder & CIO of Strategic Value Partners
33:09
33:09
Play later
Play later
Lists
Like
Liked
33:09
This episode comes from the SuperReturn conference in Berlin, with guest Victor Khosla, Founder of SVP. Set up in 2001, the firm manages $18 billion in credit, with an impressive long-term track record in identifying credit opportunities. Victor describes himself as the ‘Accidental Investor’, initially hired as a strategic consultant for a Citibank…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ask the Experts: Advances in Type 1 Diabetes Screening and Prevention Everyone Should Know
1:01:58
1:01:58
Play later
Play later
Lists
Like
Liked
1:01:58
Join us for our Ask the Experts: Advances in Type 1 Diabetes Screening and Prevention Everyone Should Know event where you'll learn about the newest advancements in screening and delaying the onset of type 1 diabetes. Listen as experts share their insights and advancements in the field. Whether you're a health care professional, a patient, or someo…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
FDA approves Sun Pharma hair loss drug, FDA issues warning letter to Brassica, EMA rejects Eisai-Biogen Alzheimer's drug [The good, the bad, the ugly]
3:46
3:46
Play later
Play later
Lists
Like
Liked
3:46
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves Sun Pharma hair loss drug The bad — FDA issues harsh warning letter to Indian CDMO Brassica The ugly — EMA issues negative opinion on Eisai-Biogen Alzheimer's drug…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
148: Greed & Fear! What to Own, What to Avoid and Are We Wrong About China? With Chris Wood, Global Head of Equity Strategy, Jefferies (Hong Kong)
42:00
42:00
Play later
Play later
Lists
Like
Liked
42:00
If you write a widely followed weekly piece for nearly 30 years, assessing investment risks & rewards, geopolitical implications, and extracting signals from noise, you need experience, good instincts, market nous, and the ability to talk to the right people. The weekly piece in question is GREED & FEAR, and its author, our guest Christopher Wood, …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Genentech's oral weight loss drug shows promise; FDA denies accelerated approval for Agenus' cancer drug; Orexo's opioid overdose drug rejected again [The good, the bad, the ugly]
3:35
3:35
Play later
Play later
Lists
Like
Liked
3:35
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Genentech's oral weight loss drug shows promise The bad — FDA denies accelerated approval for Agenus' cancer drug The ugly — Orexo's opioid overdose drug rejected again…
…
continue reading
We are more than halfway through the year and halfway through summer. The world of work has not thrown as many surprises at us over the last month but enough to ensure that Greece’s six day work-week did not feature in our top three. With Foxconn keeping married women out from certain roles, a promotion recession and neurodiversity becoming a valua…
…
continue reading
In 1999, Microsoft became the most valuable company in the world. And in 2019, Microsoft became the most valuable company in the world, again. But… what happened in the twenty years in between? The answer, as we discovered in our research, is probably not what you think. In this episode we explore and analyze the browser wars and the DOJ case, Wind…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
147: Vista Equity Partners: The $100 Billion Private Equity Software Group - With Rachel Arnold, Co-Head of Vista Equity Partners’ Endeavor Fund
23:42
23:42
Play later
Play later
Lists
Like
Liked
23:42
In this shorter interview, recorded at Berlin SuperReturn, Rachel Arnold, Co-Head of Vista’s Endeavour strategy, a fund focused on small-cap private software companies, offers insights that echo Bill Gates comment that “software is the magic thing whose importance only goes up over time” Amazingly, over 90% of software companies are private, and as…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Rerun: Morgan Stanley Chair and CEO: Succession, culture, stress, and leadership
46:50
46:50
Play later
Play later
Lists
Like
Liked
46:50
Rerun: James Gorman, one of the most successful CEOs in the world of banking, is stepping down as CEO and shares unique insights into the world of banking, investing, and leadership. He also shares how he reviews talent, and the immense stress and pressure that come with a job like his. The production team on this episode were PLAN-B's Nikolai Oven…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pfizer advances obesity pill, FDA rejects Novo insulin, FTC releases PBM report [The good, the bad, the ugly]
3:28
3:28
Play later
Play later
Lists
Like
Liked
3:28
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Pfizer advances once-daily obesity pill The bad — FDA rejects Novo Nordisk once-weekly insulin The ugly — FTC releases long-awaited report on PBMsBy Pharma Manufacturing
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Following Up! Weight Loss Q&A & More! Your Questions Answered Continues! + Mental Health Chat PART 4
13:46
13:46
Play later
Play later
Lists
Like
Liked
13:46
**Hey everyone! Welcome back for Part 4 of your Weight Loss Q&A! In this video, I'm following up on your questions from the comments and diving deeper into some of your most requested topics. Get ready for discussions on hitting a plateau - “What TO DO when the weight loss stops even after a dosage increase.” We'll also explore staying motivated an…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pregúntale a los Expertos: Manejo de la diabetes y la insuficiencia cardíaca
1:02:08
1:02:08
Play later
Play later
Lists
Like
Liked
1:02:08
Los oyentes se conectaron e hicieron preguntas a nuestros expertos sobre los riesgos de la insuficiencia cardíaca y las estrategias para su prevención y tratamiento para aquellos que manejan la diabetes. Escucha nuestro evento Pregúntale a los Expertos para aprender a reducir tu riesgo de enfermedad cardíaca, derrame cerebral y enfermedad renal cua…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
146: “Running Up That Hill” - Strava’s Co-Founder, Mike Horvath, on Building, Branding and Delivering: An Entrepreneurs’ Story
1:10:37
1:10:37
Play later
Play later
Lists
Like
Liked
1:10:37
If you wrote a business plan in the 1990s that was way ahead of its time - a 20th century idea that needed 21st century technology to work - then put it aside and instead built an enterprise software firm that achieved a Goldman Sachs backed blockbuster IPO in 1999, you might say “bravo”. If then, several years later you return to this earlier idea…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ask the Experts: Managing Diabetes and Heart Failure
1:01:35
1:01:35
Play later
Play later
Lists
Like
Liked
1:01:35
Listeners dialed in and posed questions to our experts about the risks of heart failure and the strategies for its prevention and treatment for those managing diabetes. Listen to our Ask the Experts event to learn how to reduce your risk of heart disease, stroke, and kidney disease when living with type 2 diabetes. Find more helpful resources on th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Rerun: Jensen Huang Founder and CEO of Nvidia
48:18
48:18
Play later
Play later
Lists
Like
Liked
48:18
Rerun: What’s the most important problems that AI can solve? How close are we to artificial general intelligence? And how can we use AI responsibly? Tune in and find out! The production team on this episode were PLAN-B’s Nikolai Ovenberg and Niklas Figenschau Johansen. Background research was done by Sigurd Brekke with additional input from our por…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Lilly Alzheimer’s drug gets full approval, Rocket gene therapy rejected, Eisai, BMS end ADC partnership [The good, the bad, the ugly]
3:44
3:44
Play later
Play later
Lists
Like
Liked
3:44
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA grants Eli Lilly Alzheimer’s drug full approval The bad — FDA rejects Rocket gene therapy The ugly — Eisai, BMS end ADC partnershipBy Pharma Manufacturing
…
continue reading
![Artwork](/static/images/128pixel.png)
1
“Regular People” Struggle: The Ricky Lake interview on ABC News (Reaction Video)
12:48
12:48
Play later
Play later
Lists
Like
Liked
12:48
Weight Loss & Privilege: In this video, we dissect Ricky Lake's recent interview where she discussed her 35-pound weight loss journey without medication. But wait a minute... Did she mention having a personal chef and tons of free time? This video dives into the REAL challenges everyday regular people face that celebrities often overlook. While hea…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
[Solutions Spotlight] Streamlining oral dose packaging design
31:57
31:57
Play later
Play later
Lists
Like
Liked
31:57
By integrating a Quality by Design (QbD) approach, developers can design robust packaging from the outset, drastically reducing development time and costs. Understanding how moisture affects a product is key, allowing developers to use industry-accepted and validated models to predict and address potential stability issues early in the design phase…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
David Epstein: The power of being a generalist
42:56
42:56
Play later
Play later
Lists
Like
Liked
42:56
In this episode of In Good Company, Nicolai welcomes David Epstein, author of the book Range, which challenges conventional wisdom and illustrates why generalists often thrive in a specialized world. David shares his insights on the advantages of being a generalist, the importance of a sampling period, how embracing diversity and unconventional thi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Mehrnaz Campbell in conversation with Emma Vitalini from Amgen
56:48
56:48
Play later
Play later
Lists
Like
Liked
56:48
Mehrnaz Campbell chats with Emma Vitalini, Head of Global Medical Digital Strategy at Amgen. Emma has focused her recent attention and development on the strategic build and deployment of new and evolving technologies.By Mehrnaz Campbell
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Verona wins COPD nod, FDA rejects Merck-Daiichi ADC, Glenmark recalls potassium chloride capsules [The good, the bad, the ugly]
3:42
3:42
Play later
Play later
Lists
Like
Liked
3:42
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Verona wins FDA nod for COPD The bad — FDA issues CRL to Merck-Daiichi lung cancer ADC The ugly — Glenmark recalls 114 batches of potassium chloride capsules…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
What Did Novo Nordisk VP Say on GMA? Shortage, Cost & Solutions! (We Have Answers!)
9:57
9:57
Play later
Play later
Lists
Like
Liked
9:57
Struggling to get Ozempic or Wegovy? Get the latest intel from a Novo Nordisk VP on Good Morning America! This video breaks down the interview, including what they're doing about the shortage, the high out-of-pocket costs, and future plans for obesity prevention drugs. Let's discuss - is this enough? Support the Show.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
145: Why the Fed Can’t Forecast, How Zero Rates Were a Huge Mistake and is Nvidia’s $3tn*+ Valuation Sustainable? With Rob Arnott, Founder of Research Affiliates
56:53
56:53
Play later
Play later
Lists
Like
Liked
56:53
Rob Arnott has published over 100 academic papers, co-authored several books, and his firm Research Affiliates developed the strategies behind approximately $147bn in AUM (as of March 2024). He has earned a reputation as a highly respected, value-orientated investor with clarity about unrealistic valuations, mean-reversion and where the investment …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ringing the changes: Vodafone ‘insider’ makes some tough calls as CEO
41:21
41:21
Play later
Play later
Lists
Like
Liked
41:21
Margherita Della Valle tells IMD President Jean-François Manzoni how she is delivering radical change to reenergize Vodafone and paving the way for greater diversity in leadership. -- Read our magazine, I by IMD, here. Discover IMD's leadership programmes here.By IMD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Dario Amodei CEO of Anthropic: Claude, New models, AI safety and Economic impact
1:10:51
1:10:51
Play later
Play later
Lists
Like
Liked
1:10:51
How much bigger and more powerful will the next AI models be? Anthropic’s CEO, Dario Amodei, joins Nicolai in Oslo to discuss the latest advancements in AI, the economic impact of this technology, and the importance of responsible scaling. Dario also shares his excitement about the upcoming models and his thoughts on who will profit the most from A…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Gilead HIV shot delivers zero infections, Takeda epilepsy drug misses endpoints, Lilly goes after counterfeiters [The good, the bad, the ugly]
3:36
3:36
Play later
Play later
Lists
Like
Liked
3:36
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Gilead twice-yearly HIV shot delivers zero infections in trial The bad — Takeda epilepsy drug misses endpoints in trials The ugly — Eli Lilly goes after counterfeiters…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Building a Disruptive Payments Company (with Klarna CEO Sebastian Siemiatkowski)
1:19:23
1:19:23
Play later
Play later
Lists
Like
Liked
1:19:23
The tenacity required to build Klarna over the last 19 years is astonishing. Despite several headwinds and changes in the payments landscape since founding, Klarna is used today by 150 million consumers globally, processing two million payments a day. Founder and CEO Sebastian Siemiatkowski joins us for one of the most honest and thoughtful discuss…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
HERE is How to Deal with others’ Opinions on Ozempic/Wegovy
14:18
14:18
Play later
Play later
Lists
Like
Liked
14:18
Curious about your loved ones' and others' opinions on your weight loss journey with medication? Join me as I share my Weight Loss Experience with Ozempic, Wegovy, and Mounjaro Medications, and explore what it's like to have family and friends supporting (or questioning!) your weight loss journey. Support the Show.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
144: Retail in the 21st Century: Seb James, CEO of Boots, Discusses Health, Technology, Data and the Customer
44:30
44:30
Play later
Play later
Lists
Like
Liked
44:30
In a world where competitive survival has become rarer, one UK retail institution has survived for 175 years, remains a trusted brand, with over 50,000 employees, 2,000 stores and 4,000 pharmacists. Today Boots is part of the US Walgreens Boots Alliance, an entity with sales of $140 billion (2023/24) and one of the world’s largest purchasers of pre…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Exor CEO John Elkann: Family ownership, Football and Ferrari
45:31
45:31
Play later
Play later
Lists
Like
Liked
45:31
In this episode, Nicolai sits down with John Elkann, CEO of Exor, to discuss the history of the holding company, the importance of family ownership, and the focus on long-term value creation. Exor, controlled by the Agnelli family, has companies like Ferrari, Stellantis, Philips, and the Italian football club Juventus in its portfolio. Altogether, …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ask the Experts: How to Determine a Healthy Weight for You
1:02:34
1:02:34
Play later
Play later
Lists
Like
Liked
1:02:34
Audience called in and asked questions of our experts on the importance of a healthy target weight, as well as being mindful of your target weight in respect to managing chronic diseases if you have diabetes. Listen to our Ask the Experts event to learn how to reduce your risk of heart disease, stroke, and kidney disease when living with type 2 dia…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
FDA backs Lilly Alzheimer’s drug; Pfizer Duchenne gene therapy fails; Talc plaintiffs seek J&J bankruptcy restraining order [The good, the bad, the ugly]
4:25
4:25
Play later
Play later
Lists
Like
Liked
4:25
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA AdComm backs Eli Lilly Alzheimer’s drug The bad — Pfizer gene therapy fails phase 3 Duchenne trial The ugly — Talc plaintiffs seek restraining order on J&J bankruptcy tactic…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Shitstorm eller snydere? To spørgsmål til digitaliseringsminister Marie Bjerre (2 ud af 2)
23:32
23:32
Play later
Play later
Lists
Like
Liked
23:32
Digitaliserings- og ligestillingsminister Marie Bjerre (V) er gæst i andet ud af to særafsnit af The Digital Edge. Chefredaktør Lars Jacobsen er vært - og til at hjælpe sig har han debattører med, som har et spørgsmål eller et dilemma om AI med til ministeren. Denne gang handler det blandt andet om medarbejdstilfredshed og svindel med offentlige mi…
…
continue reading